Holen Sie sich die Stockscreener-App
31.64
2.36%
0.73
Handel nachbörslich:
31.64
Schlusskurs vom Vortag:
$30.91
Offen:
$31
24-Stunden-Volumen:
272.13K
Relative Volume:
0.93
Marktkapitalisierung:
$1.02B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
26.59
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-1.12%
1M Leistung:
+6.07%
6M Leistung:
-2.80%
1J Leistung:
-4.98%
1-Tages-Spanne:
$31.00
$31.75
1-Wochen-Bereich:
$30.75
$32.47
52-Wochen-Spanne:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
31.64 | 1.03B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Is Collegium Pharmaceutical Inc. a good long term investmentRecord-breaking capital gains - Autocar Professional
What analysts say about Collegium Pharmaceutical Inc. stockLightning-fast capital gains - jammulinksnews.com
What drives Collegium Pharmaceutical Inc. stock priceBreakout portfolio performance - Autocar Professional
Collegium Pharmaceutical Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
Teacher Retirement System of Texas Decreases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical Inc. stock a good hedge against inflationBreakout Confirmation Tool - Newser
What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Investment Community - Newser
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical Breaks Above 200-Day Moving AverageBullish for COLL - Nasdaq
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Buy” at Wall Street Zen - Defense World
How To Trade (COLL) - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Lowered by Illinois Municipal Retirement Fund - Defense World
Collegium Pharmaceutical Announces Share Repurchase Program Worth $25 Million - MSN
State of Alaska Department of Revenue Decreases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
SG Americas Securities LLC Has $426,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Director’s Bold Move: Major Stock Sale at Collegium Pharmaceutical - TipRanks
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):